Cannabis Use Disorder
Cannabis use disorder is classified as the continued use of cannabis (marijuana) despite displaying an array of pathological patterns such as impaired control, social impairment, risky behavior, or physiological adaptation.
Quick Answer
What it is
Cannabis use disorder is classified as the continued use of cannabis (marijuana) despite displaying an array of pathological patterns such as impaired control, social impairment, risky behavior, or physiological adaptation.
Key findings
- Grade N/A: Marijuana Addiction (N-Acetylcysteine)
Safety
No specific caution or interaction language was detected in the current summary/outcome notes.
ℹ️ Quick Facts
Quick Facts: Cannabis Use Disorder
- Supplements Studied:1
- Research Trials:1
- Total Participants:24
- Top Supplement:N-Acetylcysteine (C)
Evidence-Based Protocol
Supplement stack ranked by research quality
Primary Stack (Tier 1)
Modulates glutamate; shown to reduce cannabis cravings and use in clinical trials
Support brain health; may help with mood and anxiety during withdrawal
Supporting Stack (Tier 2)
Supports nervous system; may help with anxiety and sleep issues during withdrawal
Often deficient in substance users; supports mood and overall health
Adaptogen that may reduce stress and anxiety during recovery
Promotes relaxation without sedation; may help with anxiety and sleep
Helps with sleep disturbances common during cannabis withdrawal
Supports nervous system function; may be depleted with chronic use
How It Works
Cannabis Use Disorder (CUD) is characterized by problematic cannabis use leading to significant impairment or distress. Signs include using more than intended, difficulty cutting down, spending excessive time obtaining or using cannabis, cravings, continued use despite problems, and withdrawal symptoms when stopping. With increasing cannabis potency and legal availability, CUD has become more common. Withdrawal symptoms include irritability, anxiety, sleep problems, decreased appetite, restlessness, and physical discomfort - typically starting 1-3 days after stopping and peaking around 1 week.
CRITICAL: While cannabis is often perceived as non-addictive, about 9% of users develop CUD (higher with earlier onset or daily use). There are currently no FDA-approved medications for CUD, but evidence-based behavioral treatments are effective: Motivational Enhancement Therapy (MET), Cognitive Behavioral Therapy (CBT), and Contingency Management. If you want to quit, consider seeking help from an addiction specialist or treatment program. These supplements may support recovery but should complement, not replace, professional treatment.
* N-Acetyl Cysteine (NAC) has the strongest evidence for CUD. Clinical trials show it modulates glutamate (disrupted by chronic cannabis use) and can reduce cravings and cannabis use, particularly in younger users.
* Omega-3 Fatty Acids support brain health and may help with mood regulation during recovery.
* Magnesium helps with anxiety and sleep - common withdrawal symptoms.
* Vitamin D is often low in substance users and supports overall health and mood.
* Ashwagandha is an adaptogen that may help manage stress and anxiety during recovery.
* L-Theanine promotes calm without sedation, helpful for anxiety.
* Melatonin addresses sleep disturbances, which are very common during cannabis withdrawal and can last weeks.
* B Vitamins support nervous system function.
Expected timeline: Acute withdrawal symptoms typically peak around day 7 and improve over 2-4 weeks. Sleep problems may persist longer. Full neurological recovery may take months of abstinence.
Supplements for Cannabis Use Disorder
Sorted by strength of evidence
Detailed Outcomes
Research Citations (34)
Related Conditions
Trichotillomania (Hair Pulling)
1 shared supplement · 4 outcomes
Trichotillomania is the compulsion to pull out one's hair.
Tobacco Use Disorder
1 shared supplement · 2 outcomes
Tobacco use disorder is a condition involving a dependence on the use of nicotine-containing tobacco products like cigarettes. It involves compulsive cravings for tobacco and cessation of use is very difficult.
Surgical Recovery
1 shared supplement · 43 outcomes
Surgical recovery refers to physiological endpoints after surgery including recovery time and adverse events including morbidity and mortality, as well as the presence of physical pain, physical comfort with everyday activities, physical independence, psychological support, and emotional well-being.
Substance Use Disorder
1 shared supplement · 2 outcomes
Substance use disorder is an abnormal mental condition characterized by an inability to control the use of legal or illegal drugs, alcohol, or medications, leading to health issues or problems at work or home.
Soccer Performance
1 shared supplement · 45 outcomes
Soccer performance refers to skills that relate to success in the sport of soccer (football) including dribbling, passing, juggling, shooting, bending, turning, goalkeeping, agility, speed, and stamina.
Schizophrenia
1 shared supplement · 69 outcomes
Schizophrenia is a brain condition that may cause auditory and/or visual hallucinations, delusions, difficulties with emotions and cognition, and verbal communication problems. These symptoms manifest between the ages of 16 and 30.
Polycystic Ovary Syndrome (PCOS)
1 shared supplement · 220 outcomes
Polycystic ovary syndrome (PCOS) is a hormone disorder that is common among women of reproductive age. PCOS is often caused by high androgen levels and frequently involves infertility, cysts on the ovaries, and metabolic abnormalities.
Overweight
1 shared supplement · 379 outcomes
Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).